Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results.
Diaz
Pablo
P
Bhaskara
Sreenivasa
S
Dursun
Serdar M
SM
Deakin
Bill
B
D000328:Adult; D000704:Analysis of Variance; D003024:Clozapine / Q000008:administration & dosage*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005998:Glycine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012033:Refractory Period, Psychological / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D003024:Clozapine; D005998:Glycine